Meningitis due to Neisseria meningitidis serogroup B in India.
Invasive meningococcal disease has a fulminant course and high mortality. Neisseria meningitidis serogroup A is predominantly responsible for meningococcal disease in India and the developing countries. Group B meningococcus, which is prevalent in the developing world is uncommon in India. We herein report the second case of group B meningococcal infection from the country, two decades after the reporting of the first case. Ineffective vaccines against serogroup B warrant the need for close surveillance of this disease.
Departments of Clinical Microbiology and Infectious Diseases Division, Chacha Nehru Bal Chikitsalaya, Raja Ram Kohli Marg, Geeta Colony, Delhi, India.
Meenakshi
M
Aggarwal
Vikas
V
Manchanda
B
B
Talukdar
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004453:Echoencephalography; D006801:Humans; D007194:India; D007223:Infant; D008297:Male; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000382:microbiology*; D038541:Neisseria meningitidis, Serogroup B / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents